Stockreport

Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targets [Yahoo! Finance]

ONO PHARM CO UNSP/ADR  (OPHLY) 
NASDAQ:AMEX Investor Relations: ono.co.jp/eng/investor/index.html
PDF it has entered into a research collaboration agreement with InveniAI ® LLC ( Guilford, Connecticut , USA; President and CEO: Krishnan Nandabalan ; "InveniAI"), to identi [Read more]